Resultados da pesquisa - Luca Gianni
- A mostrar 1 - 20 resultados de 77
- Go to Next Page
-
1
Hallmarks of triple negative breast cancer emerging at last? Por Rosa Bernardi, Luca Gianni
Publicado em 2014Artigo -
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
Relationship between HER2 expression and efficacy with first-line trastuzumab emtansine compared with trastuzumab plus docetaxel in TDM4450g: a randomized phase II study of patient... Por Edith A. Perez, Sara A. Hurvitz, Lukas C. Amler, Kirsten Mundt, Vivian Ng, Ellie Guardino, Luca Gianni
Publicado em 2014Artigo -
14
Drugs ten years later: Epirubicin Por Gianni Bonadonna, Luca Gianni, Armando Santoro, V. Bonfante, Paolo Bidoli, Paolo G. Casali, Romano Demicheli, Pinuccia Valagussa
Publicado em 1993Revisão -
15
Physical injuries caused by a transient loss of consciousness: main clinical characteristics of patients and diagnostic contribution of carotid sinus massage Por Angelo Bartoletti, Plinio Fabiani, L Bagnoli, Carlo Cappelletti, Maria Domenica Cappellini, G. Nappini, Luca Gianni, A. Lavacchi, Giovanni Maria Santoro
Publicado em 2007Artigo -
16
Defective One- or Two-electron Reduction of the Anticancer Anthracycline Epirubicin in Human Heart Por Emanuela Salvatorelli, Simone Guarnieri, Pierantonio Menna, Giovanni Liberi, Antonio M. Calafiore, Maria A. Mariggiò, Alvaro Mordente, Luca Gianni, Giorgio Minotti
Publicado em 2006Artigo -
17
Cooperative inhibitory effect of ZD1839 (Iressa) in combination with trastuzumab (Herceptin) on human breast cancer cell growth Por Nicola Normanno, Manuela Campiglio, Antonella De Luca, Giulia Somenzi, Monica R. Maiello, Fortunato Ciardiello, Luca Gianni, David S. Salomon, Sylvie Ménard
Publicado em 2002Artigo -
18
Phase I trial of oral mTOR inhibitor everolimus in combination with trastuzumab and vinorelbine in pre-treated patients with HER2-overexpressing metastatic breast cancer Por Guy Jérusalem, Angelica Fasolo, Véronique Dièras, Fátima Cardoso, Jonas Bergh, Luc Vittori, Yufen Zhang, Cristian Massacesi, Tarek Sahmoud, Luca Gianni
Publicado em 2010Artigo -
19
Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer? Por Chiara Lazzari, Niki Karachaliou, Alessandra Bulotta, Mariagrazia Viganò, Aurora Mirabile, Elena Brioschi, Mariacarmela Santarpía, Luca Gianni, Rafael Rosell, Vanesa Gregorc
Publicado em 2018Revisão -
20
A phase I study of PankoMab-GEX, a humanised glyco-optimised monoclonal antibody to a novel tumour-specific MUC1 glycopeptide epitope in patients with advanced carcinomas Por Walter Fiedler, S. DeDosso, Sara Cresta, Jens Weidmann, Anna Tessari, Marc Salzberg, B. Dietrich, Harald Baumeister, Steffen Goletz, Luca Gianni, Cristiana Sessa
Publicado em 2016Artigo
Ferramentas de pesquisa:
Assuntos relacionados
Medicine
Internal medicine
Cancer
Oncology
Breast cancer
Chemotherapy
Trastuzumab
Biology
Metastatic breast cancer
Surgery
Cancer research
Biochemistry
Adjuvant
Gastroenterology
Pertuzumab
Anthracycline
Clinical trial
Confidence interval
Environmental health
Population
Chemistry
Immunology
Immunotherapy
Hazard ratio
Taxane
Triple-negative breast cancer
Adverse effect
Cyclophosphamide
Docetaxel
Gene